Moore, S E <br/><br/>
Effect of warfarin sodium therapy on excretion of 4-carboxy-L-glutamic acid in scleroderma, dermatomyositis, and myositis ossificans progressiva.  [electronic resource] 

 -  Arthritis and rheumatism  Mar 1986 
 - 344-51 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.1780290306  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bone and Bones--diagnostic imaging<br/>Calcium--urine<br/>Carbon Radioisotopes<br/>Chromatography, High Pressure Liquid<br/>Cyclic AMP--urine<br/>Dermatomyositis--urine<br/>Female<br/>Follow-Up Studies<br/>Glutamates--urine<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Myositis Ossificans--urine<br/>Phosphorus--urine<br/>Radiography<br/>Radionuclide Imaging<br/>Scleroderma, Systemic--urine<br/>Warfarin--adverse effects